Did you miss out on 'attending'
the Parkinson's Australia
You can still register to access the
'View on Demand' videos of the presentations
Parkinson’s Australia is pleased to announce that the long standing shortage of a formulation of Levodopa/Carbidopa 200/50 (Sinemet CR) has been resolved.
The manufacturers, MSD (Merck, Sharp & Dohme) Australia, have announced that this medication is once again available. The only change is that Sinemet CR will now be packed in a bottle containing 100 tablets as opposed to the previous packaging in a blister pack containing 60 tablets.
Naturally any queries about prescribing of this medication should be directed to your treating medical specialist.